A detailed history of Brendel Financial Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Brendel Financial Advisors LLC holds 106,983 shares of PFE stock, worth $2.94 Million. This represents 1.76% of its overall portfolio holdings.

Number of Shares
106,983
Previous 106,858 0.12%
Holding current value
$2.94 Million
Previous $2.99 Million 3.55%
% of portfolio
1.76%
Previous 1.9%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$27.7 - $31.39 $3,462 - $3,923
125 Added 0.12%
106,983 $3.1 Million
Q2 2024

Jul 15, 2024

BUY
$25.26 - $29.6 $2.7 Million - $3.16 Million
106,858 New
106,858 $2.99 Million
Q4 2023

Feb 01, 2024

BUY
$26.13 - $33.94 $2.59 Million - $3.36 Million
99,131 New
99,131 $2.85 Million
Q1 2023

Apr 06, 2023

BUY
$39.39 - $51.28 $5.26 Million - $6.85 Million
133,502 New
133,502 $5.45 Million
Q2 2022

Jul 26, 2022

SELL
$46.53 - $55.17 $2.19 Million - $2.6 Million
-47,130 Reduced 32.12%
99,618 $5.22 Million
Q1 2022

May 10, 2022

BUY
$45.75 - $56.69 $2.15 Million - $2.67 Million
47,035 Added 47.17%
146,748 $7.6 Million
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $4.12 Million - $6.11 Million
99,713 New
99,713 $5.89 Million
Q3 2021

Oct 26, 2021

SELL
$39.25 - $50.42 $3.91 Million - $5.02 Million
-99,609 Closed
0 $0
Q3 2020

Nov 04, 2020

SELL
$31.75 - $37.25 $4,222 - $4,954
-133 Reduced 0.13%
99,609 $3.66 Million
Q4 2019

Feb 04, 2020

SELL
$32.92 - $37.36 $7,407 - $8,406
-225 Reduced 0.23%
99,742 $3.91 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $9,747 - $12,639
-300 Reduced 0.3%
99,967 $3.59 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $58,500 - $64,272
-1,560 Reduced 1.53%
100,267 $4.26 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $3.92 Million - $4.47 Million
101,827 New
101,827 $4.45 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Brendel Financial Advisors LLC Portfolio

Follow Brendel Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brendel Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brendel Financial Advisors LLC with notifications on news.